Efficacy, safety and prognostic factors in patients with refractory metastatic colorectal cancer treated with trifluridine/tipiracil plus bevacizumab in a real-world setting

por Martínez-Lago, Nieves, Chucla, Teresa Calleja, De Castro, Beatriz Alonso, Ponte, Rafael Varela, Rendo, Cristina Reboredo, Rodriguez, Martin Igor Gomez-Randulfe, Diaz, Sofia Silva, Suarez, Begoña Graña, de la Cámara Gomez, Juan, Fernández, Fernando Busto, Salvador, María Mateos, Lopez, Margarita Reboredo
Publicado 2022